'Cetuximab folfiri' presentation slideshows

Eric Van Cutsem*

KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer treated with FOLFIRI with or without cetuximab: The CRYSTAL experience. Eric Van Cutsem*

524 views • 26 slides

Eric Van Cutsem*, M Nowacki, I Lang, S Cascinu, I Shchepotin, J Maurel,

489 views • 24 slides

Eric Van Cutsem*, I. Lang, G. Folprecht, M. Nowacki , S. Cascinu, I. Shchepotin , J. Maurel,

Cetuximab plus FOLFIRI in the treatment of metastatic colorectal cancer: the influence of KRAS and BRAF biomarkers on outcome: updated data from the CRYSTAL trial. Eric Van Cutsem*, I. Lang, G. Folprecht, M. Nowacki , S. Cascinu, I. Shchepotin , J. Maurel, D. Cunningham, P. Rougier,

279 views • 16 slides